AI
Wednesday, June 27, 2012 10:09:26 AM
Maybe iclight is AF? 
I think it's important to note that there are reasons as to why Simes doesn't go out and advertise that they plan on submitting an NDA for Libigel as a preventative method to reduce CV events or for TRT.
For one he can't until Biosante is 100 percent certain that they can move forward with it. This probably won't occur until they reveal the results of the 9th safety study.
Why they can't advertise it? There are legal reasons to consider here. They have to be careful not to mislead investors. Doing so could sprout up lawsuits.
I think it's important to note that there are reasons as to why Simes doesn't go out and advertise that they plan on submitting an NDA for Libigel as a preventative method to reduce CV events or for TRT.
For one he can't until Biosante is 100 percent certain that they can move forward with it. This probably won't occur until they reveal the results of the 9th safety study.
Why they can't advertise it? There are legal reasons to consider here. They have to be careful not to mislead investors. Doing so could sprout up lawsuits.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
